In PC sections, 46% (± 15%) of cancer cells were CD44-positive (Figure 1B and Supplementary Figure 1B), indicating that nearly half of all PC tumor cells expressed this stem cell marker. The gene discussed is CD44; the disease is pachyonychia congenita.